Elizabeth Glaser Pediatric Aids Foundation is categorized under Medical Research in Santa Monica, CA .
Elizabeth Glaser Pediatric Aids Foundation was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Jeff Gaffney at the company’s branch by writing to 2950 31st St # 125, Santa Monica, California CA 90405 or by phoning (310) 314-1459. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Elizabeth Glaser Pediatric Aids Foundation |
| Contact Person: | Jeff Gaffney |
| Address: | 2950 31st St # 125, Santa Monica, California 90405 |
| Phone Number: | (310) 314-1459 |
| Website Address: | pedaids.org |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Elizabeth Glaser Pediatric Aids Foundation was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jeff Gaffney for inquiries that concern Elizabeth Glaser Pediatric Aids Foundation by calling the company number (310) 314-1459, as your correspondence is most welcome. Additionally, the physical location of the branch of Elizabeth Glaser Pediatric Aids Foundation can be found at the coordinates 34.018711,-118.451164 as well as the street address 2950 31st St # 125 in Santa Monica, California 90405.
For its online presence, you may visit Elizabeth Glaser Pediatric Aids Foundation’s website at pedaids.org and engage with its social media outlets through on Twitter and on Facebook.